EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned hereby agree that the Schedule 13D with respect to the Common Stock of RegeneRx Biopharmaceuticals, Inc. dated as of July 2, 2021, is, and any amendments thereto signed by such of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
| ESSETIFIN S.P.A. | ||
| By: | /s/ Marino Zigrossi | |
| Name: | Marino Zigrossi | |
| Title: | Attorney-in-fact | |
| Date: | July 2, 2021 | |
| PAOLO CAVAZZA | ||
| By: | /s/ Fabio Poma | |
| Name: | Fabio Poma | |
| Title: | Attorney-in-fact | |
| Date: | July 2, 2021 | |
| ENRICO CAVAZZA | ||
| By: | /s/ Marino Zigrossi | |
| Name: | Marino Zigrossi | |
| Title: | Attorney-in-fact | |
| Date: | July 2, 2021 | |
| FRANCESCA CAVAZZA | ||
| By: | /s/ Marino Zigrossi | |
| Name: | Marino Zigrossi | |
| Title: | Attorney-in-fact | |
| Date: | July 2, 2021 | |
| SILVIA CAVAZZA | ||
| By: | /s/ Marino Zigrossi | |
| Name: | Marino Zigrossi | |
| Title: | Attorney-in-fact | |
| Date: | July 2, 2021 | |
EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned hereby agree that the Schedule 13D with respect to the Common Stock of RegeneRx Biopharmaceuticals, Inc. dated as of July 2, 2021, is, and any amendments thereto signed by such of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
MARTINA CAVAZZA PRETA
| By: | /s/ Marino Zigrossi | |
| Name: | Marino Zigrossi | |
| Title: | Attorney-in-fact | |
| Date: | July 2, 2021 | |
| APTAFIN S.P.A. | ||
| By: | /s/ Emanuela Belletti | |
| Name: | Emanuela Belletti | |
| Title: | CEO | |
| Date: | July 2, 2021 | |
| APTAFIN FINANCE SA | ||
| By: | /s/ Tiffany Halsdorf | |
| Name: | Tiffany Halsdorf | |
| Title: | Director | |
| Date: | July 2, 2021 | |
| By: | /s/ Giorgio Bianchi | |
| Name: | Giorgio Bianchi | |
| Title: | Director | |
| Date: | July 2, 2021 | |
